electroCore, Inc. (NASDAQ:ECOR – Get Free Report) Director Thomas Errico purchased 9,992 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The shares were acquired at an average cost of $5.99 per share, with a total value of $59,852.08. Following the completion of the purchase, the director directly owned 360,071 shares in the company, valued at $2,156,825.29. The trade was a 2.85% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
electroCore Stock Performance
Shares of ECOR stock opened at $8.91 on Wednesday. electroCore, Inc. has a 52-week low of $4.16 and a 52-week high of $9.23. The firm has a market capitalization of $73.92 million, a P/E ratio of -5.03 and a beta of 0.68. The stock has a 50 day moving average price of $6.43 and a 200 day moving average price of $6.02.
electroCore (NASDAQ:ECOR – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.59). electroCore had a negative return on equity of 1,956.38% and a negative net margin of 44.08%.The firm had revenue of $9.58 million during the quarter, compared to analyst estimates of $9.01 million. As a group, sell-side analysts forecast that electroCore, Inc. will post -1.48 EPS for the current year.
Institutional Investors Weigh In On electroCore
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the company. raised electroCore to a “strong-buy” rating in a research note on Tuesday, February 3rd. Zacks Research raised electroCore from a “strong sell” rating to a “hold” rating in a research report on Friday, March 27th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a research report on Friday, March 27th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $18.00.
View Our Latest Report on electroCore
About electroCore
electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.
The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.
Further Reading
- Five stocks we like better than electroCore
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
